CA3041016C - Method for the management of dysmenorrhea and menstrual pain - Google Patents

Method for the management of dysmenorrhea and menstrual pain Download PDF

Info

Publication number
CA3041016C
CA3041016C CA3041016A CA3041016A CA3041016C CA 3041016 C CA3041016 C CA 3041016C CA 3041016 A CA3041016 A CA 3041016A CA 3041016 A CA3041016 A CA 3041016A CA 3041016 C CA3041016 C CA 3041016C
Authority
CA
Canada
Prior art keywords
estetrol
component
dysmenorrhea
estetrol component
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3041016A
Other languages
English (en)
French (fr)
Other versions
CA3041016A1 (en
Inventor
Maud JOST
Glwadys RAUSIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Estetra SRL
Original Assignee
Estetra SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Estetra SRL filed Critical Estetra SRL
Priority to CA3178291A priority Critical patent/CA3178291A1/en
Publication of CA3041016A1 publication Critical patent/CA3041016A1/en
Application granted granted Critical
Publication of CA3041016C publication Critical patent/CA3041016C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3041016A 2016-08-05 2016-10-28 Method for the management of dysmenorrhea and menstrual pain Active CA3041016C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3178291A CA3178291A1 (en) 2016-08-05 2016-10-28 Method for the management of dysmenorrhea and menstrual pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2016/076104 WO2018065076A1 (en) 2016-10-28 2016-10-28 Method for the management of dysmenorrhea and menstrual pain

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3178291A Division CA3178291A1 (en) 2016-08-05 2016-10-28 Method for the management of dysmenorrhea and menstrual pain

Publications (2)

Publication Number Publication Date
CA3041016A1 CA3041016A1 (en) 2018-04-12
CA3041016C true CA3041016C (en) 2023-09-05

Family

ID=57209484

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3041016A Active CA3041016C (en) 2016-08-05 2016-10-28 Method for the management of dysmenorrhea and menstrual pain

Country Status (5)

Country Link
JP (1) JP2018533542A (ko)
KR (1) KR20190076014A (ko)
AU (1) AU2016425935B2 (ko)
CA (1) CA3041016C (ko)
WO (1) WO2018065076A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
WO2016203009A1 (en) 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible tablet containing estetrol
GEP20217243B (en) 2015-06-18 2021-04-26 Sprl Estetra Orodispersible dosage unit containing an estetrol component
NO3106148T3 (ko) 2015-06-18 2018-08-11
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
UY38075A (es) 2018-02-07 2019-10-01 Estetra Sprl Composiciones anticonceptivas con efectos cardiovasculares reducidos
TWI801561B (zh) * 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
HU231240B1 (hu) 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
IT202000003964A1 (it) * 2020-02-26 2021-08-26 Umberto Cornelli Composizione farmaceutica per l’uso nel trattamento di dismenorrea e/o sindrome premestruale
WO2022166599A1 (zh) * 2021-02-02 2022-08-11 广州沪同有梧生物科技有限公司 Pqq 及其衍生物的新应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344405C2 (de) 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
WO2012055840A1 (en) * 2010-10-28 2012-05-03 Bayer Pharma Aktiengesellschaft Composition and preparation for treatment of dysmenorrhea and menstrual pain and use of a hormonal agent and a zinc salt for treatment of menstrual disorders
KR20220144885A (ko) * 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법

Also Published As

Publication number Publication date
JP2018533542A (ja) 2018-11-15
WO2018065076A1 (en) 2018-04-12
KR20190076014A (ko) 2019-07-01
CA3041016A1 (en) 2018-04-12
AU2016425935A1 (en) 2019-05-16
AU2016425935B2 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
AU2022231672B2 (en) Method for the management of dysmenorrhea and menstrual pain
CA3041016C (en) Method for the management of dysmenorrhea and menstrual pain
RU2169567C2 (ru) Способ контрацепции женщин репродуктивного возраста, не достигших предменопаузы
KR101812160B1 (ko) 연장된 호르몬성 피임제 투약법에서 파탄성 출혈의 관리
US20200046729A1 (en) Methods using combined oral contraceptive compositions with reduced cardiovascular effects
NZ262657A (en) Hormone replacement therapy using estrogen and antiprogestin
EP1796725B1 (en) Treatment or prevention of unscheluded bleeding in women on progestogen containing medication
JP2007533681A (ja) 天然エストロゲンに基づく段階型避妊製剤
Von Schoultz Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment
JP2008527018A (ja) 避妊用医薬製剤
JPH08508502A (ja) 骨粗しょう症の治療方法および治療用組成物
US20080280861A1 (en) Method of Female Contraception and a Kit For Use Therein
Burkman Chapter Hormonal Contraception

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210504

EEER Examination request

Effective date: 20210504

EEER Examination request

Effective date: 20210504

EEER Examination request

Effective date: 20210504

EEER Examination request

Effective date: 20210504

EEER Examination request

Effective date: 20210504

EEER Examination request

Effective date: 20210504